Literature DB >> 19877103

Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Rohit Aggarwal1, Katherine Liao, Raj Nair, Sarah Ringold, Karen H Costenbader.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19877103      PMCID： PMC2859449          DOI： 10.1002/art.24827

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  159 in total

1.  Anti-keratin antibodies in rheumatoid arthritis.

Authors:  B J Young; R K Mallya; R D Leslie; C J Clark; T J Hamblin
Journal:  Br Med J       Date:  1979-07-14

2.  Second generation anti-cyclic citrullinated peptide (anti-CCP2) antibodies can replace other anti-filaggrin antibodies and improve rheumatoid arthritis diagnosis.

Authors:  S Grootenboer-Mignot; P Nicaise-Roland; C Delaunay; O Meyer; S Chollet-Martin; C Labarre
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

3.  Antibodies against cyclic citrullinated peptide (CCP) and levels of cartilage oligomeric matrix protein (COMP) in very early arthritis: relation to diagnosis and disease activity.

Authors:  M K Söderlin; A Kastbom; H Kautiainen; M Leirisalo-Repo; G Strandberg; T Skogh
Journal:  Scand J Rheumatol       Date:  2004       Impact factor: 3.641

4.  Is Anti Cyclic citrullinated peptide a useful laboratory test for the diagnosis of rheumatoid arthritis?

Authors:  F Girelli; F G Foschi; E Bedeschi; V Calderoni; G F Stefanini; M G Martinelli
Journal:  Eur Ann Allergy Clin Immunol       Date:  2004-04

5.  Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.

Authors:  C Alessandri; M Bombardieri; N Papa; M Cinquini; L Magrini; A Tincani; G Valesini
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

6.  Diagnostic and clinical value of anti-cyclic citrullinated peptide antibodies compared with rheumatoid factor isotypes in rheumatoid arthritis.

Authors:  I Vallbracht; J Rieber; M Oppermann; F Förger; U Siebert; K Helmke
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

7.  Diagnostic characteristics of a gelatin based Waaler-Rose assay (Serodia-RA) for the detection of rheumatoid factor.

Authors:  T Spiritus; P Verschueren; R Westhovens; X Bossuyt
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

8.  Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP).

Authors:  K Forslind; M Ahlmén; K Eberhardt; I Hafström; B Svensson
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

9.  Anti-CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project).

Authors:  A Kastbom; G Strandberg; A Lindroos; T Skogh
Journal:  Ann Rheum Dis       Date:  2004-09       Impact factor: 19.103

10.  A combination of autoantibodies to cyclic citrullinated peptide (CCP) and HLA-DRB1 locus antigens is strongly associated with future onset of rheumatoid arthritis.

Authors:  Ewa Berglin; Leonid Padyukov; Ulf Sundin; Göran Hallmans; Hans Stenlund; Walther J Van Venrooij; Lars Klareskog; Solbritt Rantapää Dahlqvist
Journal:  Arthritis Res Ther       Date:  2004-05-11       Impact factor: 5.156
View more
  63 in total

1.  The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.

Authors:  Tuhina Neogi; Daniel Aletaha; Alan J Silman; Raymond L Naden; David T Felson; Rohit Aggarwal; Clifton O Bingham; Neal S Birnbaum; Gerd R Burmester; Vivian P Bykerk; Marc D Cohen; Bernard Combe; Karen H Costenbader; Maxime Dougados; Paul Emery; Gianfranco Ferraccioli; Johanna M W Hazes; Kathryn Hobbs; Tom W J Huizinga; Arthur Kavanaugh; Jonathan Kay; Dinesh Khanna; Tore K Kvien; Timothy Laing; Katherine Liao; Philip Mease; Henri A Ménard; Larry W Moreland; Raj Nair; Theodore Pincus; Sarah Ringold; Josef S Smolen; Ewa Stanislawska-Biernat; Deborah Symmons; Paul P Tak; Katherine S Upchurch; Jirí Vencovský; Frederick Wolfe; Gillian Hawker
Journal:  Arthritis Rheum       Date:  2010-09

2.  Rheumatoid arthritis in the Women's Health Initiative: methods and baseline evaluation.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Larry W Moreland
Journal:  Am J Epidemiol       Date:  2014-02-24       Impact factor: 4.897

3.  Associations of autoantibodies, autoimmune risk alleles, and clinical diagnoses from the electronic medical records in rheumatoid arthritis cases and non-rheumatoid arthritis controls.

Authors:  Katherine P Liao; Fina Kurreeman; Gang Li; Grant Duclos; Shawn Murphy; Raul Guzman; Tianxi Cai; Namrata Gupta; Vivian Gainer; Peter Schur; Jing Cui; Joshua C Denny; Peter Szolovits; Susanne Churchill; Isaac Kohane; Elizabeth W Karlson; Robert M Plenge
Journal:  Arthritis Rheum       Date:  2013-03

Review 4.  Inflammation and rheumatoid arthritis.

Authors:  Amit Kumar Shrivastava; Aparna Pandey
Journal:  J Physiol Biochem       Date:  2012-10-31       Impact factor: 4.158

5.  Cellular and humoral immunity in arthritis are profoundly influenced by the interaction between cigarette smoke effects and host HLA-DR and DQ genes.

Authors:  Robert Vassallo; David Luckey; Marshall Behrens; Benjamin Madden; Harvinder Luthra; Chella David; Veena Taneja
Journal:  Clin Immunol       Date:  2014-02-14       Impact factor: 3.969

6.  Effect of Porphyromonas gingivalis infection on gut dysbiosis and resultant arthritis exacerbation in mouse model.

Authors:  Yuta Hamamoto; Kazuhisa Ouhara; Syuichi Munenaga; Mikio Shoji; Tatsuhiko Ozawa; Jyunzo Hisatsune; Isamu Kado; Mikihito Kajiya; Shinji Matsuda; Toshihisa Kawai; Noriyoshi Mizuno; Tsuyoshi Fujita; Shintaro Hirata; Kotaro Tanimoto; Koji Nakayama; Hiroyuki Kishi; Eiji Sugiyama; Hidemi Kurihara
Journal:  Arthritis Res Ther       Date:  2020-10-19       Impact factor: 5.156

7.  T cell responses to citrullinated self-peptides in patients with rheumatoid arthritis.

Authors:  Amita Aggarwal; Rajni Srivastava; Suraksha Agrawal
Journal:  Rheumatol Int       Date:  2013-03-31       Impact factor: 2.631

Review 8.  Reliable and cost-effective serodiagnosis of rheumatoid arthritis.

Authors:  Pieter W A Meyer; Mahmood M T M Ally; Ronald Anderson
Journal:  Rheumatol Int       Date:  2016-02-09       Impact factor: 2.631

9.  Extensive Citrullination Promotes Immunogenicity of HSP90 through Protein Unfolding and Exposure of Cryptic Epitopes.

Authors:  Timothy S Travers; Lisa Harlow; Ivan O Rosas; Bernadette R Gochuico; Ted R Mikuls; Sanjoy K Bhattacharya; Carlos J Camacho; Dana P Ascherman
Journal:  J Immunol       Date:  2016-07-22       Impact factor: 5.422

10.  Determinants of mortality among postmenopausal women in the women's health initiative who report rheumatoid arthritis.

Authors:  Lewis H Kuller; Rachel H Mackey; Brian T Walitt; Kevin D Deane; V Michael Holers; William H Robinson; Jeremy Sokolove; Yuefang Chang; Simin Liu; Christine G Parks; Nicole C Wright; Larry W Moreland
Journal:  Arthritis Rheumatol       Date:  2014-03       Impact factor: 10.995
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.